Analysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...

The Renal Sympathetic Nervous System The pathophysiology of essential hypertension is complex and multifactorial. It is thought that abnormal renal excretory function plays a central role in the ...

Endovascular ultrasound for renal sympathetic denervation appears to be a safe and effective treatment option among patients with therapy-resistant hypertension who do not respond to ...

PARIS, France—With renal denervation on the cusp of gaining a place in clinical practice for the treatment of hypertension, researchers are looking more closely at other conditions associated with ...

About the Paradise Ultrasound Renal Denervation System The Paradise uRDN system is a first-of-its-kind ultrasound-based RDN ...

The United States Food and Drug Administration, in 2023, approved renal denervation—a catheter-based procedure that ablates the renal sympathetic nerves—as an adjunctive treatment for patients ...

Evidence-based recommendations on alcohol-mediated perivascular renal sympathetic denervation for resistant hypertension. This involves putting alcohol into the wall of a renal artery to destroy renal ...

Medtronic is studying the use of its nitinol-enabled Symplicity Spyral renal denervation (RDN) catheter combined with hepatic ...

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval.

Given these worrying data and frequent poor response to currently available antihypertensive therapies, recent novel strategies targeting the renal sympathetic nervous system offer the potential ...